The Global Fertility Supplement Market is valued at USD 1.85 Billion in 2021 and is expected to reach USD 3.07 Billion by 2028 with a CAGR of 7.49% over the forecast period.
Global Fertility Supplement Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis to 2022-2028, Increasing number of fertility problems, rising number of cases of hormonal imbalances and growing consumption of alcohol and drugs are some of the major factors driving the growth of the Global Fertility Supplement Market.
To improve the chances of pregnancy and having a healthy baby, fertility supplements are taken. Natural and synthetic ingredients are used to boost the fertility by promoting ovulation and improving hormonal profiles. Men and women should definitely consider taking fertility supplements when looking to improve or support their egg, ovulatory, sperm, or overall reproductive health.
The Covid-19 pandemic has constructively affected the demand for fertility supplements. As a consequence, the consumption of fertility supplements has increased gradually augmented during the outbreak. Though, the lockdown and limitations on international trade disrupted the supply chain and generated an enormous gap between the supply and demand of the supplement.
Some of the key players for global Fertility Supplement are:
The global Fertility Supplement market is segmented based on product type, ingredients, procedure, service provider, end-users, distribution channel, and region & country level. Based on products type, the global fertility supplement market is classified into capsules, tablets, soft gels, powders and liquids. Based on ingredients, the market is classified into natural, synthetic and blend of synthetic and natural ingredients. On basis of procedure, the global fertility supplement market is classified as IVF with ICSI, IUI, Surrogacy, IVF without ICSI and others. On the basis of service providers, the market is classified into fertility clinics, hospitals, surgical centers and clinical research institutes. Based on end-user, the global fertility supplement market is classified into men and women. On basis of distribution channel, the market is classified as OTC and prescribed.
The regions covered in this global fertility supplement market report are Asia-Pacific, North America, Europe, and the Rest of the World. Based on a country level, the market of fertility supplement is subdivided into the U.S., Canada, Brazil, Mexico, Germany, U.K., France, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
An increase in the consumption of alcohol, drugs, and smoking, is vigorously propelling the fertility supplement market growth. Smoking damages the genetic material in sperm and eggs, offspring birth-defect rates, and miscarriage are higher among patients who smoke. There are large numbers of smokers across the globe. For example, as per the National Center for Chronic Disease Prevention and Health Promotion, approximately 14 of each 100 U.S. adults aged 18 years or older smoked cigarettes in 2019 which means on an average 34.1 million adults in the United States presently smoke cigarettes. The increased consumption of alcohol and cigarette leads to amplified miscarriage rates as well as bad effects on fertility by varying sperm size, count, shape, and motility. While the studies have revealed that fertility does advance after dropping the habit of smoking. For improving the fertility rate, people will need to intake the proper supplements which help them to have a healthy baby.
To boot, the unceasing decline in fertility rates and late pregnancies in women are other factors supplementing the fertility supplement market growth globally. The overall trend in declining fertility rates, nevertheless, is basically owing to women's varying roles, employment shifts, and developments in reproductive health. Failures of infertility have been concentrated especially among younger Americans. Teen fertility has dropped by more than 75% in current decades, all the way down to 15.3 births per 1,000 women. Moreover, established countries tend to have a lesser fertility rate owing to lifestyle selections related to economic affluence where mortality rates are low. The continued decline of fertility across the world is leading to the demand for supplements which increases the rate of delivery. Fertility supplements can increase the probabilities of conceiving and carrying the baby to term. That’s why the inclination of masses of people is increasingly enhancing towards fertility supplements. As a consequence, this factor is dynamically booming the fertility supplement market growth worldwide.
Apart from many driving factors, soaring illegal selling of fertility supplements among many players may harm the fertility supplement market growth. For instance; in May 2021, FDA and the FTC issued joint warning letters to about five fertility supplement brands that had made illegal disease-treatment claims. On the contrary, an upsurge in demand for natural ingredients is anticipated to offer new opportunities for the market players in the upcoming years.
On a geographic basis, North America is expected to dominate the global fertility supplement market owing to many factors such as the increasing prevalence of fertility problems, recent development, and the presence of a large number of players in this region. For example; about 6% of married women aged 15 to 44 years in the United States are unable to get pregnant after one year of trying (infertility). Also, about 12% of women aged 15 to 44 years in the United States have difficulty getting pregnant or carrying a pregnancy to term (impaired fecundity). Research & development on fertility supplements has become more progressive in current years, which have unlocked new avenues for brands. Research and developments are stimulating consideration in a various array of fertility supplements, both in terms of product format and active ingredients.
Europe is another fastest-growing region in the fertility supplement market due to the rising frequency of obesity and the expanding number of diabetic patients. However, obese and overweight women have upper levels of a hormone called leptin, which is produced in fatty tissue. This can disturb the hormone balance and result in reduced fertility. In accordance with Eurostat, weight difficulties and obesity are growing at a hasty rate in most of the EU Member States, with around 52.7% of the adult EU's population overweight in 2019. As well, when broken down, almost 58.6% of European adults are overweight and 23 percent are obese in 2020. Moreover, the study of Brandessence market research analysts displays that the risks of infertility have been shown to be threefold higher in obese than in non-obese women. Obese women are more desirable to intake fertility supplements to get pregnant and have a healthy baby. This is fruitfully boosting the fertility supplements market growth and making the European region the fastest-growing region globally.
On October 22nd, 2021; Everly Health, a parent company of home testing startup Everlywell Health had acquired Natalist, reproductive health startup. Natalist’s suite of products such as prenatal supplements, ovulation tests, and pregnancy tests will add on to Everly Health’s prevailing at-home lab collection tests for areas like menopause and fertility hormones.
On May 20th, 2020; An online health startup, Ro (Roman) that sells erectile dysfunction medication and hair loss supplements to men, announced the acquisition of Modern Fertility, a reproductive health platform that permits users to order customized fertility hormone tests online.
On May 5th, 2020; A startup company, WellSource Nutraceuticals situated in Purdue Research Park of Northwest Indiana, generated a nutritional supplement to help women infertility programs. Methyl-NX is intended to precisely address the exclusive design criteria to support in vitro fertilization and fertility programs.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2021:||USD 1.85 Billion|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 3.07 Billion|
|Tables, Charts & Figures:||175|
|Fertility Supplements Companies||Active Bio Life Science GmbH, Amino Expert (Innovamed Ltd.), Babystart Ltd., Bionova, CellOxess LLC, Coast Science, Crown Nutraceuticals, Exeltis USA, Inc., extreme V, Inc., Fairhaven Health, Fertility Nutraceuticals LLC, Gonadosan, Lenus Pharma GesmbH, Orthomol, PregPrep LLC, Sal Nature, TTK Healthcare Ltd., VH Nutrition LLC, Vitabiotics Ltd., YadTech|
|Segments Covered||By Types of Fertility Supplements, By Ingredients, By Form, By Gender, By Distribution Channel|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|